H-group (homology)
4169.1 Coronavirus spike protein receptor-binding domain
Ligands and drugs
5,131
Member domains
3,174
with ligand contacts (≤ 4 Å)
61.9% of members
1,568
with DrugDomain annotations
30.6% of members
1,543
with a DrugBank compound
30.1% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 4169.1 belongs to X-group 4169 Coronavirus spike protein receptor-binding domain, which binds 4.6 ligand superclasses per 20 proteins, narrower than 87% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 1,452 |
| DB14104 | EIC | Linoleic acid | 72 |
| DB04224 | ELA | Oleic Acid | 6 |
| DB00755 | REA | Tretinoin | 3 |
| DB03193 | STE | Stearic acid | 3 |
| DB03796 | PLM | Palmitic Acid | 3 |
| DB00142 | GLU | Glutamic acid | 2 |
| DB00172 | PRO | Proline | 2 |
| DB03740 | NDG | N-acetyl-alpha-D-glucosamine | 2 |
| DB04473 | FUC | alpha-L-fucose | 2 |
| DB03175 | POL | Propyl alcohol | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 3,041 |
| EIC | LINOLEIC ACID | 102 |
| CL | CHLORIDE ION | 34 |
| 8Z9 | Sapienic acid | 19 |
| PLM | PALMITIC ACID | 9 |
| STE | STEARIC ACID | 9 |
| KZ0 | 2,4,6-tris(chloromethyl)-1,3,5-triazine | 7 |
| ELA | Elaidic acid | 6 |
| IDU | 2-O-sulfo-beta-L-altropyranuronic acid | 3 |
| NAmetal | SODIUM ION | 3 |
| OLA | OLEIC ACID | 3 |
| PG0 | 2-(2-METHOXYETHOXY)ETHANOL | 3 |
| PRO | PROLINE | 3 |
| Q83 | 7-(6-nitro-2,3-dihydroindol-1-yl)-7-oxidanylidene-heptanoic acid | 3 |
| REA | RETINOIC ACID | 3 |
| VCG | 2-hydroxyethyl 2-deoxy-3,5-bis-O-(2-hydroxyethyl)-6-O-(2-{[(9E)-octadec-9-enoyl]oxy}ethyl)-alpha-L-xylo-hexofuranoside | 3 |
| MGmetal | MAGNESIUM ION | 2 |
| NDG | 2-acetamido-2-deoxy-alpha-D-glucopyranose | 2 |
| P4G | 1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE | 2 |
| XIO | [(2~{S})-2-[[4-(2-azanylethanoylamino)-7-[[(2~{S})-3-[2-(4-nitrophenyl)sulfanyl-1~{H}-indol-3-yl]-1-oxidanylidene-1-sodiooxy-propan-2-yl]amino]-4-[3-[[(2~{S})-3-[2-(4-nitrophenyl)sulfanyl-1~{H}-indol-3-yl]-1-oxidanylidene-1-sodiooxy-propan-2-yl]amino]-3-oxidanylidene-propyl]-7-oxidanylidene-heptanoyl]amino]-3-[2-(4-nitrophenyl)sulfanyl-1~{H}-indol-3-yl]propanoyl]oxysodium | 2 |